The emergence of new trends in clinical laboratory diagnosis

References

1. ↵
   1. Santiago DN,
   2. Heidbuechel JPW,
   3. Kandell WM,
   4. Walker R,
   5. Djeu J,
   6. Engeland CE,
   7. et al.

   (2017) Fighting cancer with mathematics and viruses. Viruses 9:239.

   OpenUrl
2. ↵
   1. Konstorum A,
   2. Vella AT,
   3. Adler AJ,
   4. Laubenbacher RC

   (2017) Addressing current challenges in cancer immunotherapy with mathematical and computational modelling. J R Soc Interface 14:20170150.

   OpenUrlCrossRefPubMed
3. ↵
   1. Das A,
   2. Nair MS,
   3. Peter SD

   (2020) Computer-aided histopathological image analysis techniques for automated nuclear atypia scoring of breast cancer:A review. J Digit Imaging 27:doi:10.1007/s10278-019-00295-z.
4. ↵
   1. Komura D,
   2. Ishikawa S

   (2018) Machine learning methods for histopathological image analysis. Comput Struct Biotechnol J 16:34–42.

   OpenUrl
5. ↵
   1. Ghesu F,
   2. Georgescu B,
   3. Zheng Y,
   4. Grbic S,
   5. Maier A,
   6. Hornegger J,
   7. et al.

   (2019) Multi-scale deep reinforcement learning for real-time 3D-landmark detection in CT scans. IEEE Trans Pattern Anal Mach Intell 41:176–189.

   OpenUrl
6. ↵
   1. Maier A,
   2. Syben C,
   3. Lasser T,
   4. Riess C

   (2019) A gentle introduction to deep learning in medical image processing. Z Med Phys 29:86–101.

   OpenUrlPubMed
7. ↵
   1. Zhang YD,
   2. Dong Z

   (2018) Special issue on “medical imaging &Image processing II” Technologies 6:doi.org/10.3390/technologies6020039.
8. ↵
   1. Jiang F,
   2. Jiang Y,
   3. Zhi H,
   4. Dong Y,
   5. Li H,
   6. Ma S,
   7. et al.

   (2017) Artificial intelligence in healthcare:past, present and future. Stroke Vasc Neurol 2:230–243.

   OpenUrlAbstract/FREE Full Text
9. ↵
   1. Park SH,
   2. Kim YH,
   3. Lee JY,
   4. Yoo S,
   5. Kim CJ

   (2019) Ethical challenges regarding artificial intelligence in medicine from the perspective of scientific editing and peer review. Sci Ed 6:91–98.

   OpenUrl
10. ↵
    1. Dias R,
    2. Torkamani A

    (2019) Artificial intelligence in clinical and genomic diagnostics. Genome Med 11:70.

    OpenUrl
11. ↵
    1. Theel ES

    (2016) The Past, Present, and (Possible) Future of Serologic Testing for Lyme Disease. J Clin Microbiol 54:1191–1196.

    OpenUrlAbstract/FREE Full Text
12. ↵
    1. Beigh MM

    (2016) Next-generation sequencing:The translational medicine approach from “Bench to Bedside to Population” Medicines (Basel) 3:14.

    OpenUrl
13. ↵
    1. Cristea D,
    2. Trandafir M,
    3. Bojinca VC,
    4. Ciontea AS,
    5. Andrei MM,
    6. Popa A,
    7. et al.

    (2019) Usefulness of complex bacteriological and serological analysis in patients with spondyloarthritis. Exp Ther Med 17:3465–3476.

    OpenUrl
14. ↵
    1. Eliçabe RJ,
    2. Silva JE,
    3. Dave MN,
    4. Lacoste MG,
    5. Tamashiro H,
    6. Blas R,
    7. et al.

    (2017) Association between IL-17 and IgA in the joints of patients with inflammatory arthropathies. BMC Immunol 18:8.

    OpenUrl
15. ↵
    1. Westblade LF,
    2. van Belkum A,
    3. Grundhoff A,
    4. Weinstock GM,
    5. Pamer EG,
    6. Pallen MJ,
    7. et al.

    (2016) Role of clinicogenomics in infectious disease diagnostics and public health microbiology. J Clin Microbiol 54:1686–1693.

    OpenUrlAbstract/FREE Full Text
16. 1. Hendriksen RS,
    2. Bortolaia V,
    3. Tate H,
    4. Tyson GH,
    5. Aarestrup FM,
    6. McDermott PF

    (2019) Using Genomics to Track Global Antimicrobial Resistance. Front Public Health 7:242.

    OpenUrl
17. 1. Gwinn M,
    2. MacCannell DR,
    3. Khabbaz RF

    (2017) Integrating Advanced Molecular Technologies into Public Health. J Clin Microbiol 55:703–714.

    OpenUrlAbstract/FREE Full Text
18. ↵
    1. Armstrong GL,
    2. MacCannell DR,
    3. Taylor J,
    4. Carleton HA,
    5. Neuhaus EB,
    6. Bradbury RS,
    7. et al.

    (2019) Pathogen genomics in public health. N Engl J Med 381:2569–2580.

    OpenUrlCrossRef
19. ↵
    1. Thanthrige-Don N,
    2. Lung O,
    3. Furukawa-Stoffer T,
    4. Buchanan C,
    5. Joseph T,
    6. Godson DL,
    7. et al.

    (2018) A novel multiplex PCR-electronic microarray assay for rapid and simultaneous detection of bovine respiratory and enteric pathogens. J Virol Methods 261:51–62.

    OpenUrl
20. ↵
    1. Karimi R,
    2. Hajdu A

    (2016) HTSFinder:Powerful pipeline of DNA Signature discovery by parallel and distributed computing. Evol Bioinform Online 12:73–85.

    OpenUrl
21. ↵
    1. Wang L,
    2. Wang Y,
    3. Li H,
    4. Feng X,
    5. Yuan D,
    6. Yang J

    (2019) A bidirectional label propagation based computational model for potential microbe-disease association prediction. Front Microbiol 10:684.

    OpenUrl
22. ↵
    1. Qu J,
    2. Zhao Y,
    3. Yin J

    (2019) Identification and analysis of human microbe-disease associations by matrix decomposition and label propagation. Front Microbiol 10:291.

    OpenUrl
23. ↵
    1. Vigne E,
    2. Garcia S,
    3. Komar V,
    4. Lemaire O,
    5. Hily JM

    (2018) Comparison of serological and molecular methods with high-throughput sequencing for the detection and quantification of grapevine fanleaf virus in vineyard samples. Front Microbiol 9:2726.

    OpenUrl
24. ↵
    1. Caraballo Cortes K,
    2. Rosińska M,
    3. Janiak M,
    4. Stępień M,
    5. Zagordi O,
    6. Perlejewski K,
    7. et al.

    (2018) Next-generation sequencing analysis of a cluster of hepatitis C virus infections in a haematology and oncology center. PLoS One 13:e0194816.

    OpenUrlCrossRef
25. ↵
    1. López-Palau NE,
    2. Olais-Govea JM

    (2020) Mathematical model of blood glucose dynamics by emulating the pathophysiology of glucose metabolism in type 2 diabetes mellitus. Sci Rep 10:12697.

    OpenUrl
26. ↵
    1. Tura A,
    2. Chemello G,
    3. Szendroedi J,
    4. Göbl C,
    5. Færch K,
    6. Vrbíková J,
    7. et al.

    (2018) Prediction of clamp-derived insulin sensitivity from the oral glucose insulin sensitivity index. Diabetologia 61:1135–1141.

    OpenUrlPubMed
27. ↵
    1. Khan F,
    2. Khan MA,
    3. Abbas S,
    4. Athar A,
    5. Siddiqui SY,
    6. Khan AH,
    7. et al.

    (2020) Cloud-based breast cancer prediction empowered with soft computing approaches. J Healthc Eng 2020, 8017496.
28. ↵
    1. Glover NM,
    2. Altenhoff A,
    3. Dessimoz C

    (2019) Assigning confidence scores to homoeologs using fuzzy logic. Peer J 6:e6231.

    OpenUrl
29. ↵
    1. Goyal M,
    2. Khanna D,
    3. Rana PS,
    4. Khaibullin T,
    5. Martynova E,
    6. Rizvanov AA,
    7. et al.

    (2019) Computational intelligence technique for prediction of multiple sclerosis based on serum cytokines. Front Neurol 10:781.

    OpenUrl
30. ↵
    1. McGarrity S,
    2. Halldórsson H,
    3. Palsson S,
    4. Johansson PI,
    5. Rolfsson Ó

    (2016) Understanding the causes and implications of endothelial metabolic variation in cardiovascular disease through genome-scale metabolic modeling. Front Cardiovasc Med 3:10.

    OpenUrl
31. ↵
    1. Eftimie R,
    2. Hassanein E

    (2018) Improving cancer detection through combinations of cancer and immune biomarkers:a modelling approach. J Transl Med 16:73.

    OpenUrl
32. ↵
    1. Bittl JA,
    2. He Y

    (2017) Bayesian Analysis:A Practical Approach to Interpret Clinical Trials and Create Clinical Practice Guidelines. Circ Cardiovasc Qual Outcomes 10:e003563.

    OpenUrlAbstract/FREE Full Text
33. ↵
    1. da Silva JG,
    2. de Morais RM,
    3. da Silva ICR,
    4. de Arruda Mancera PF

    (2019) Mathematical models applied to thyroid cancer. Biophys Rev 11:183–189.

    OpenUrl
34. ↵
    1. Atwater T,
    2. Cook CM,
    3. Massion PP

    (2016) The pursuit of noninvasive diagnosis of lung cancer. Semin Respir Crit Care Med 37:670–680.

    OpenUrl
35. ↵
    1. Emmaneel A,
    2. Bogaert DJ,
    3. Van Gassen S,
    4. Tavernier SJ,
    5. Dullaers M,
    6. Haerynck F,
    7. et al.

    (2019) A computational pipeline for the diagnosis of CVID patients. Front Immunol 10:2009.

    OpenUrl
36. ↵
    1. Pan L,
    2. Segrest JP

    (2016) Computational studies of plasma lipoprotein lipids. Biochim Biophys Acta 1858:2401–2420.

    OpenUrl
37. ↵
    1. Fischer CL,
    2. Bates AM,
    3. Lanzel EA,
    4. Guthmiller JM,
    5. Johnson GK,
    6. Singh NK,
    7. et al.

    (2019) Computational models accurately predict multi-cell biomarker profiles in inflammation and cancer. Sci Rep 9:10877.

    OpenUrl
38. ↵
    1. Wise AL,
    2. Manolio TA,
    3. Mensah GA,
    4. Peterson JF,
    5. Roden DM,
    6. Tamburro C,
    7. et al.

    (2019) Genomic medicine for undiagnosed diseases. Lancet 394:533–540.

    OpenUrlCrossRef
39. ↵
    1. Di Resta C,
    2. Galbiati S,
    3. Carrera P,
    4. Ferrari M

    (2018) Next-generation sequencing approach for the diagnosis of human diseases:open challenges and new opportunities. EJIFCC 29:4–14.

    OpenUrl
40. 1. Posey JE,
    2. O'Donnell-Luria AH,
    3. Chong JX,
    4. Harel T,
    5. Jhangiani SN,
    6. Coban Akdemir ZH,
    7. et al.

    (2019) Insights into genetics, human biology and disease gleaned from family based genomic studies. Genet Med 21:798–812.

    OpenUrlPubMed
41. ↵
    1. Jackson M,
    2. Marks L,
    3. May GHW,
    4. Wilson JB

    (2018) The genetic basis of disease. Essays Biochem 62:643–723.

    OpenUrlAbstract/FREE Full Text
42. ↵
    1. Stenson PD,
    2. Mort M,
    3. Ball EV,
    4. Evans K,
    5. Hayden M,
    6. Heywood S,
    7. et al.

    (2017) The Human Gene Mutation Database:towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet 136:665–677.

    OpenUrlCrossRefPubMed
43. ↵
    1. Pereira R,
    2. Oliveira J,
    3. Sousa M

    (2020) Bioinformatics and computational tools for next-generation sequencing analysis in clinical genetics. J Clin Med 9:132.

    OpenUrl
44. ↵
    1. Smith SL,
    2. Lones MA,
    3. Bedder M,
    4. Alty JE,
    5. Cosgrove J,
    6. Maguire RJ,
    7. et al.

    (2015) Computational approaches for understanding the diagnosis and treatment of Parkinson's disease. IET Syst Biol 9:226–233.

    OpenUrlCrossRef
45. ↵
    1. Vaser R,
    2. Adusumalli S,
    3. Leng SN,
    4. Sikic M,
    5. Ng PC

    (2016) SIFT missense predictions for genomes. Nat Protoc 11:1–9.

    OpenUrlCrossRefPubMed
46. ↵
    1. Anna A,
    2. Monika G

    (2018) Splicing mutations in human genetic disorders:examples, detection, and confirmation. J Appl Genet 59:253–268.

    OpenUrlCrossRef
47. 1. Ohno K,
    2. Takeda JI,
    3. Masuda A

    (2018) Rules and tools to predict the splicing effects of exonic and intronic mutations. Wiley Interdiscip Rev RNA 9:doi:10.1002/wrna.1451.
48. ↵
    1. Zhou Y,
    2. Fujikura K,
    3. Mkrtchian S,
    4. Lauschke VM

    (2018) Computational methods for the pharmacogenetic interpretation of next generation sequencing data. Front Pharmacol 9:1437.

    OpenUrl
49. ↵
    1. Visscher PM,
    2. Wray NR,
    3. Zhang Q,
    4. Sklar P,
    5. McCarthy MI,
    6. Brown MA,
    7. et al.

    (2017) 10 Years of GWAS Discovery:Biology, Function, and Translation. Am J Hum Genet 101:5–22.

    OpenUrlCrossRefPubMed
50. ↵
    1. Camargo AV,
    2. Mackay I,
    3. Mott R,
    4. Han J,
    5. Doonan JH,
    6. Askew K,
    7. et al.

    (2018) Functional Mapping of Quantitative Trait Loci (QTLs) associated with plant performance in a wheat MAGIC mapping population. Front Plant Sci 9:887.

    OpenUrl
51. ↵
    1. Abels E,
    2. Pantanowitz L,
    3. Aeffner F,
    4. Zarella MD,
    5. van der Laak J,
    6. Bui MM,
    7. et al.

    (2019) Computational pathology definitions, best practices, and recommendations for regulatory guidance:a white paper from the Digital Pathology Association. J Pathol 249:286–294.

    OpenUrlPubMed
52. 1. Robertson S,
    2. Azizpour H,
    3. Smith K,
    4. Hartman J

    (2018) Digital image analysis in breast pathology-from image processing techniques to artificial intelligence. Transl Res 194:19–35.

    OpenUrlPubMed
53. ↵
    1. Louis DN,
    2. Feldman M,
    3. Carter AB,
    4. Dighe AS,
    5. Pfeifer JD,
    6. Bry L,
    7. et al.

    (2016) Computational pathology:A path ahead. Arch Pathol Lab Med 140:41–50.

    OpenUrlPubMed
54. ↵
    1. Serag A,
    2. Ion-Margineanu A,
    3. Qureshi H,
    4. McMillan R,
    5. Saint Martin MJ,
    6. Diamond J,
    7. et al.

    (2019) Translational AI and deep learning in diagnostic pathology. Front Med (Lausanne) 6:185.

    OpenUrl
55. 1. Yasuda Y,
    2. Tokunaga K,
    3. Koga T,
    4. Sakamoto C,
    5. Goldberg IG,
    6. Saitoh N,
    7. et al.

    (2020) Computational analysis of morphological and molecular features in gastric cancer tissues. Cancer Med 9:2223–2234.

    OpenUrl
56. 1. Harmon SA,
    2. Tuncer S,
    3. Sanford T,
    4. Choyke PL,
    5. Türkbey B

    (2019) Artificial intelligence at the intersection of pathology and radiology in prostate cancer. Diagn Interv Radiol 25:183–188.

    OpenUrl
57. ↵
    1. Yi F,
    2. Huang J,
    3. Yang L,
    4. Xie Y,
    5. Xiao G

    (2017) Automatic extraction of cell nuclei from H&E-stained histopathological images. J Med Imaging (Bellingham) 4:027502.

    OpenUrl
58. ↵
    1. Power SP,
    2. Moloney F,
    3. Twomey M,
    4. James K,
    5. O'Connor OJ,
    6. Maher MM

    (2016) Computed tomography and patient risk:Facts, perceptions and uncertainties. World J Radiol 8:902–915.

    OpenUrlCrossRef
59. ↵
    1. Grover VPB,
    2. Tognarelli JM,
    3. Crossey MME,
    4. Cox IJ,
    5. Taylor-Robinson SD,
    6. McPhail MJW

    (2015) Magnetic resonance imaging:principles and techniques:Lessons for clinicians. J Clin Exp Hepatol 5:246–255.

    OpenUrl
60. ↵
    1. Vaquero JJ,
    2. Kinahan P

    (2015) Positron emission tomography:Current challenges and opportunities for technological advances in clinical and preclinical imaging systems. Annu Rev Biomed Eng 17:385–414.

    OpenUrl